ArticleOncoimmunology

Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.

Bangrong Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.